ARGOS Incident Reporting in Argentina: Platform, FSCA and FSN Duties

1. Key takeaways

Medical device incident reporting in Argentina is submitted uniformly through ANMAT’s ARGOS digital platform (under Disposición ANMAT 8194/2023), covering three categories of content: serious adverse event reports, Field Safety Corrective Action (FSCA) notifications, and trend reports. The platform is therefore not an optional channel or one reporting route among several; it is the single legal gateway through which every vigilance obligation under the regulation is fulfilled. A company that has not operationalized ARGOS access has, in effect, no functioning vigilance compliance in Argentina.

For foreign manufacturers, the practical consequence of platform concentration is that vigilance performance in Argentina is executed through a third party. Event awareness, threshold judgment, and submission all run through the registration holder’s account, so the manufacturer’s compliance depends on an interface it does not control directly. The agreement between the parties is therefore not a formality but the operative compliance document: it must specify transfer deadlines, escalation contacts on both sides, and the evidence each party keeps of its own step in the chain, so that any later dispute about a missed deadline can be reconstructed from documents rather than from recollection.

FSCA follow a dual-track action: notify ANMAT within 10 calendar days of implementation, and issue the Field Safety Notice (FSN) to users without delay. ARGOS also includes a public library where FSCA reports are open to society at large, which means a company’s compliance record is, quite literally, its public reputation. Every corrective action taken in the Argentine market becomes a visible data point for hospitals, distributors, competitors, and regulators alike.

2. Legal basis

3. Expert insights

Insight 1: ARGOS accounts belong to the registration holder, and manufacturers cannot submit directly. Because device registration in Argentina is held by a local registration holder, the operating credentials for ARGOS sit with that holder as well. The manufacturer must therefore agree with the registration holder, in writing, on the transfer deadlines for event information, the division of responsibility for threshold determinations, and the confirmation feedback after each submission. This is the interface where disputes most commonly arise after the fact. When a serious event occurs, the manufacturer knows first, but only the holder can file, and any ambiguity about who does what, by when, converts directly into missed statutory deadlines. Contractual clarity established in peacetime is the only reliable protection.

Insight 2: The public nature of FSCA changes the company’s decision calculus. Because the ARGOS public library makes FSCA reports open to society, every corrective action leaves a public record. When deciding whether to initiate an FSCA, a company must weigh both its compliance obligation and the brand impact of a public record, but it must never delay a report out of concern for publicity. Late reporting is itself a violation, and it compounds the original problem: the company ends up defending both the device issue and the reporting failure. Reputationally, a promptly reported and well-managed corrective action reads far better than a disclosure forced by a regulator after a missed deadline.

Insight 3: The “without delay” standard for FSN is an independent obligation. The FSN faces users, while the FSCA notification faces ANMAT; these are two parallel actions, not one action with two outputs. The 10 calendar days is the deadline for the FSCA notification. For the FSN, the regulation gives no specific number of days and instead uses the standard of without delay. In practice, the FSN should be launched in the same batch as the FSCA notification or even earlier, because users are the ones exposed to the residual risk while the paperwork is being processed. Treating the FSN as a follow-up step after the notification is a misreading of the obligation.

Insight 4: Every ARGOS submission carries a timestamp, and the record is cumulative. A company’s reporting history on the platform becomes an auditable timeline of its vigilance performance: the intervals between awareness and submission, the consistency between FSCA decisions and their notifications, and the completeness of trend reports all sit in one place for the regulator to review. This cumulative visibility cuts both ways. A history of punctual, well-documented filings builds credibility that colors how ANMAT reads any future incident, while a history of late or inconsistent submissions invites deeper scrutiny of everything else the company does. Companies should therefore manage ARGOS not as a series of isolated transactions but as a longitudinal record, and the contractual interface with the registration holder should reflect that: the holder’s submissions are, in substance, the manufacturer’s public compliance history, filed under the manufacturer’s product name.

4. Practical recommendations

1. Define the ARGOS division of labor in the registration holder agreement. The manufacturer handles event detection and initial assessment; the registration holder handles platform submission; both sides agree on an information transfer deadline, with a recommended limit of no more than 24 hours.
2. Apply for the ARGOS account and complete access configuration in advance. Complete the account application, operator training, and a test submission before the first product is certified. Do not open the account only when an event occurs, when every minute of setup time is subtracted from the statutory deadline.
3. Prepare FSN templates and a list of distribution channels. Pre-build Spanish-language FSN templates by product line and user type, and confirm the issuing channels in advance: distributor notification, direct letters to hospitals, and website announcements.
4. Document every FSCA decision in writing. Record why an FSCA was or was not initiated, the assessment basis, and the timeline, so the file can be produced during any later inspection or audit.

5. Verification checklist

• □ The ARGOS account has been applied for and operators have completed training
• □ The information transfer deadline between manufacturer and registration holder has been agreed in the contract
• □ Submission processes for serious events, FSCA, and trend reports have been established
• □ The process of notifying FSCA to ANMAT within 10 calendar days of implementation has been formalized
• □ Spanish-language FSN templates have been pre-built by product line
• □ The list of FSN distribution channels has been confirmed
• □ A written record mechanism for FSCA decisions has been established

Regulatory information verified as of October 29, 2026.

In Argentina, GRZAN operates a wholly owned subsidiary that can act as the registration holder and importer for foreign manufacturers, directly handling classification assessment, pathway selection, GMP and CFS documentation chains, Spanish-language technical documentation and label localization, HELENA submissions and deficiency responses, as well as BONITA import notifications, ARGOS vigilance system operation, change maintenance, and 5-year renewal planning.

The GRZAN regulatory team consists of professionals with many years of hands-on international registration experience, tracking the developments of regulators worldwide. All external content follows the drafting standard of conclusions first, traceable basis, and verifiable numbers. For a market access plan tailored to your specific product for Argentina or the MERCOSUR region, contact the GRZAN regulatory team at info@grzanglobal.com.